OriginalInvestigation | Nutrition,Obesity,andExercise
EffectofaLow-FatVeganDietonBodyWeight,InsulinSensitivity,
PostprandialMetabolism,andIntramyocellularandHepatocellularLipidLevels
inOverweightAdults
ARandomizedClinicalTrial
HanaKahleova,MD,PhD;KittFalkPetersen,MD;GeraldI.Shulman,MD,PhD;JihadAlwarith,BS;EmilieRembert,BS;AndreaTura,PhD;MartinHill,PhD;
RichardHolubkov,PhD;NealD.Barnard,MD
Abstract KeyPoints
Question Whataretheeffectsofa
IMPORTANCE Excessbodyweightandinsulinresistanceleadtotype2diabetesandothermajor
low-fatvegandietonbodyweight,
healthproblems.Thereisanurgentneedfordietaryinterventionstoaddresstheseconditions.
insulinresistance,postprandial
metabolism,andintramyocellularand
OBJECTIVE Tomeasuretheeffectsofalow-fatvegandietonbodyweight,insulinresistance,
hepatocellularlipidlevelsin
postprandialmetabolism,andintramyocellularandhepatocellularlipidlevelsinoverweightadults.
overweightadults?
DESIGN,SETTING,ANDPARTICIPANTS This16-weekrandomizedclinicaltrialwasconducted Findings Inthis16-weekrandomized
betweenJanuary2017andFebruary2019inWashington,DC.Of3115peoplewhorespondedto clinicaltrial,alow-fatplant-based
flyersinmedicalofficesandnewspaperandradioadvertisements,244mettheparticipationcriteria dietaryinterventionreducedbody
(age25to75years;bodymassindexof28to40)afterhavingbeenscreenedbytelephone. weightbyreducingenergyintakeand
increasingpostprandialmetabolism,
INTERVENTIONS Participantswererandomizedina1:1ratio.Theinterventiongroup(n=122)was whichwasassociatedwithreductionsin
askedtofollowalow-fatvegandietandthecontrolgroup(n=122)tomakenodietchangesfor hepatocellularandintramyocellularfat
16weeks. andincreasedinsulinsensitivity.
Meaning Alow-fatplant-baseddietis
MAINOUTCOMESANDMEASURES Atweeks0and16,bodyweightwasassessedusinga
aneffectivetoolforreducingbody
calibratedscale.Bodycompositionandvisceralfatweremeasuredbydualx-rayabsorptiometry.
weightandincreasinginsulinsensitivity
Insulinresistancewasassessedwiththehomeostasismodelassessmentindexandthepredicted
andpostprandialmetabolism.
insulinsensitivityindex(PREDIM).Thermiceffectoffoodwasmeasuredbyindirectcalorimetryover
3hoursafterastandardliquidbreakfast(720kcal).Inasubsetofparticipants(n=44),
+
hepatocellularandintramyocellularlipidswerequantifiedbyprotonmagneticresonance Supplementalcontent
spectroscopy.Repeatedmeasureanalysisofvariancewasusedforstatisticalanalysis. Authoraffiliationsandarticleinformationare
listedattheendofthisarticle.
RESULTS Amongthe244participantsinthestudy,211(87%)werefemale,117(48%)wereWhite,
andthemean(SD)agewas54.4(11.6)years.Overthe16weeks,bodyweightdecreasedinthe
interventiongroupby5.9kg(95%CI,5.0-6.7kg;P<.001).Thermiceffectoffoodincreasedinthe
interventiongroupfrombaselineto16weeksanddidnotchangesignificantlyinthecontrolgroup
(between-groupdifferenceineffectsize,14.1%;95%CI,6.5-20.4;P<.001).Thehomeostasismodel
assessmentindexdecreased(−1.3;95%CI,−2.2to−0.3;P<.001)andPREDIMincreased(0.9;95%
CI,0.5-1.2;P<.001)intheinterventiongroup.Hepatocellularlipidlevelsdecreasedinthe
interventiongroupby34.4%,fromamean(SD)of3.2%(2.9%)to2.4%(2.2%)(P=.002),and
intramyocellularlipidlevelsdecreasedby10.4%,fromamean(SD)of1.6(1.1)to1.5(1.0)(P=.03).
Noneofthesevariableschangedsignificantlyinthecontrolgroupoverthe16weeks.Thechangein
PREDIMcorrelatednegativelywiththechangeinbodyweight(r=−0.43;P<.001).Changesin
(continued)
OpenAccess.ThisisanopenaccessarticledistributedunderthetermsoftheCC-BYLicense.
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 1/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
Abstract(continued)
hepatocellularandintramyocellularlipidlevelscorrelatedwithchangesininsulinresistance(both
r=0.51;P=.01).
CONCLUSIONSANDRELEVANCE Alow-fatplant-baseddietaryinterventionreducesbodyweight
byreducingenergyintakeandincreasingpostprandialmetabolism.Thechangesareassociatedwith
reductionsinhepatocellularandintramyocellularfatandincreasedinsulinsensitivity.
TRIALREGISTRATION ClinicalTrials.govIdentifier:NCT02939638
JAMANetworkOpen.2020;3(11):e2025454.
CorrectedonMay27,2021.doi:10.1001/jamanetworkopen.2020.25454
Introduction
Overweightandassociateddiseases,particularlytype2diabetesandmetabolicsyndrome,remain
worldwidechallenges.Thereisanurgentneedfordietaryinterventionstoaddresstheseproblems
andforabetterunderstandingofhowdifferentdietaryinterventionswork.
Obesityisuncommoninindividualswhosedietsarebasedonplant-derivedfoods.1,2Inclinical
trials,suchdietscausedweightloss,forwhich2explanationshavebeenoffered.3First,ahigh-fiber,
low-fatdiethasalowenergydensity,whichreducesenergyintake.Second,alow-fat,vegandiet
increasesthethermiceffectoffood,whichaccountsforapproximately10%oftotalenergy
expenditure.4However,inthelatterrandomizedclinicaltrial,thecontrolgroupwasfollowingan
activedietbasedonNationalCholesterolEducationProgramguidelines.5Becausetherewasno
untreatedcontrolgroup,theeffectofalow-fatvegandietonthermogenesisremainsunclear.
Studieshavereportedthatpeoplefollowingavegandiethavelowerconcentrationsof
intramyocellularlipidscomparedwiththosefollowingomnivorousdiets,suggestingthatbyreducing
intramyocellularorhepatocellularlipidlevels,aplant-baseddietmayleadtoincreasedmitochondrial
activityandpostprandialmetabolism.6,7Thisisparticularlyimportantbecausetheaccumulationof
lipidsinmuscleandlivercellsmayalsobeassociatedwithinsulinresistanceandtype2diabetes.8-10
Theaimofthisstudywastomeasuretheeffectsofalow-fatvegandietonbodyweight,insulin
resistance,postprandialmetabolism,andintramyocellularandhepatocellularlipidlevelsin
overweightadults.
Methods
StudyDesignandEligibility
Thisrandomizedclinicaltrialusingasingle-center,openparalleldesignwasconductedbetween
January2017andFebruary2019inWashington,DC,in4replications(thetrialprotocolisgivenin
Supplement1).Adultsaged25to75yearswithabodymassindex(BMI)(calculatedasweightin
kilogramsdividedbyheightinmeterssquared)of28to40wereenrolled.Exclusioncriteriawere
diabetes,smoking,alcoholordruguse,pregnancyorlactation,andcurrentuseofavegandiet.The
additionalexclusioncriteriaforthesubsetofparticipantsundergoingtheprotonmagneticresonance
spectroscopywerethepresenceofanymetalimplant,claustrophobia,BMIhigherthan38,andwaist
circumferenceofmorethan102cm.ThestudyprotocolwasapprovedbytheChesapeake
InstitutionalReviewBoard.Allparticipantsgavewritteninformedconsent.Thisstudyfollowedthe
ConsolidatedStandardsofReportingTrials(CONSORT)reportingguideline.11
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 2/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
RandomizationandStudyGroups
Withuseofacomputer-generatedsystem,participantswererandomlyassigned(ina1:1ratio)toan
interventiongroup,whichwasaskedtofollowalow-fatvegandiet,oracontrolgroup,whichwas
askedtomakenodietchanges.Therandomizationprotocolcouldnotbeaccessedbythe
participantsorthestaffallocatingtheparticipantsintogroupsbeforehand.Becauseassignmentwas
donesimultaneously,allocationconcealmentwasunnecessary.Theparticipantswerenotblinded
totheirgroupassignment.
Theinterventiondiet(approximately75%ofenergyfromcarbohydrates,15%protein,and10%
fat)consistedofvegetables,grains,legumes,andfruitswithoutanimalproductsoraddedfats.
VitaminB wassupplemented(500μg/d).Theinterventiongroupattendedweeklyclassesfor
12
detailedinstructionandcookingdemonstrationsandreceivedprintedmaterialsandsmallfood
samples.Nomealswereprovided.
Forbothgroups,alcoholicbeverageswerelimitedto1perdayforwomenand2perdayformen.
Allparticipantswereaskedtomaintaintheircustomaryexercisehabitsandmedicationsunless
modifiedbytheirpersonalphysicians.
Outcomes
Allmeasurementswereperformedatbaselineand16weeks.Theoutcomeassessors(K.F.P.,G.I.S.,
andA.T.)wereblindedtogroupassignment.Theprimaryoutcomeswerebodyweight,insulin
resistance,postprandialmetabolism,andtheconcentrationsofintramyocellularand
hepatocellularlipids.
Atbaselineandat16weeks,dietaryintakedataover3consecutivedayswerecollectedand
analyzedbystaffmemberscertifiedintheNutritionDataSystemforResearch,version2016,
developedbytheNutritionCoordinatingCenter,UniversityofMinnesota,Minneapolis.12Inaddition,
studydietitiansmadeunannouncedtelephonecallstoassessparticipants’dietaryadherence.All
studyparticipantswereaskednottoaltertheirexercisehabitsandtocontinuetheirpreexisting
medicationregimensforthedurationofthestudy.PhysicalactivitywasassessedbytheInternational
PhysicalActivityQuestionnaire.13
Laboratoryassessmentsweremadeafteranovernightfast.Height(baselineonly)andweight
weremeasuredusingastadiometerandacalibrateddigitalscale,respectively.Bodycompositionand
visceralfatvolumewereassessedusingdualenergyx-rayabsorptiometry(iDXA;GEHealthcare),
whichhasbeenvalidatedagainstcomputedtomography14andmagneticresonanceimaging.15The
measurementoftotalbodyfatandvisceralfathadacoefficientofvariation(CV)of1.0%and5.4%,
respectively.16,17
Insulinsecretionwasassessedafterastandardizedliquidbreakfast(BoostPlus,Nestle)(720
kcal,34%ofenergyfromfat,16%protein,and50%carbohydrate).Plasmaglucose,immunoreactive
insulin,andC-peptideconcentrationsweremeasuredat0,30,60,120,and180minutes.Plasma
glucoseconcentrationwasanalyzedusingtheHexokinaseUVendpointmethod(theintra-assayCV
was1.4%,andtheinter-assayCVwas1.9%),andimmunoreactiveinsulinandC-peptide
concentrationsweredeterminedusinginsulinandC-peptideelectro-chemiluminescence
immunoassay(theintra-assayCVswere5.1%and3.8%,respectively,andtheinter-assayCVswere
5.7%and3.9%,respectively).Glycatedhemoglobinlevelwasmeasuredbyturbidimetricinhibition
immunoassay(theintra-assayCVwas3.7%,andtheinter-assayCVwas3.5%),andlipid
concentrationsweremeasuredbyenzymaticcolorimetricmethods(intra-assayCV:totalcholesterol,
2.1%;high-densitylipoproteincholesterol,2.4%;low-densitylipoproteincholesterol,2.0%;and
triglycerides2.2%;inter-assayCV:totalcholesterol,2.7%;high-densitylipoproteincholesterol,3.8%;
low-densitylipoproteincholesterol,3.0%;andtriglycerides3.2%).AlltestkitsweremadebyRoche.
Insulinresistancewascalculatedusingthehomeostasismodelassessmentindex.18The
predictedinsulinsensitivityindex(PREDIM)providedavalidatedmeasureofdynamicinsulin
sensitivity.19Restingenergyexpenditureandpostprandialmetabolismweremeasuredbyindirect
calorimetry(CosmedQuarkCPET)usingaventilatedhoodsystem(accuracyofmeasurementwitha
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 3/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
CV<1%andrepeatabilityofmeasurementwithaCVof1.2%).20,21Eachmeasurementwasperformed
for15minutesafteranovernightfastand30,60,120,and180minutesafterthestandardbreakfast.
Inasubsetof44participants(23intheinterventiongroupand21inthecontrolgroup),proton
magneticresonancespectroscopywasperformedattheMagneticResonanceResearchCenter,Yale
SchoolofMedicine.Hepatocellularandintramyocellularlipidswerequantifiedbyprotonmagnetic
resonancespectroscopyat4T(Bruker).22Thismethodhasbeenshowntoprovideaprecise
quantificationoffatfractions,withameanbiasof−1.1.%to0.5%.23Hepatocellularlipidcontentwas
measuredby1Hrespiratory-gatedstimulatedechoacquisitionmodespectroscopyina
15×15×15-mm3voxel.Acquisitionwassynchronizedtotherespiratorycycleandtriggeredatthe
endofexpiration.Awater-suppressedlipidspectrumandalipid-suppressedwaterspectrumwere
acquiredin3locationsofthelivertoaccountforliverinhomogeneity,andthetotallipidcontentwas
averagedandcalculated.Inaddition,hepatocellularlipidcontentwascorrectedfortransverse
relaxationusingthetransverserelaxationtimesof22msforwaterand44msforlipid.24
Intramyocellularlipidcontentwasmeasuredinthesoleusmuscleusingan8.5-cmdiametercircular
13Csurfacecoilwithtwin,orthogonalcircular13-cm1Hquadraturecoils.Scoutimagesofthelowerleg
wereobtainedtoensurecorrectpositioningoftheparticipantandtodefineanadequatevolumefor
localizedshimmingusingtheFastMapprocedure.25
PowerAnalysis
Samplesizewasbasedonthechangeinbodyweight,insulinresistance,andpostprandial
metabolismpreviouslyobservedwithaplant-baseddiet,4withanαlevelof0.05.Theassumed
changeforbodyweightwasamean(SD)of5.8(3.2)kgintheinterventionarmand1(3.2)kginthe
controlarm;forinsulinsensitivity,theassumedchangewas1.1(2.1)intheinterventionarmand0.1
(2.1)inthecontrolarm;andforthethermiceffectoffood,theassumedchangewas4.7(12)(area
underthecurve)intheinterventionarmand0.3(9.4)inthecontrolarm.Fortheprimaryefficacy
comparison,atotalof22participants(11perarm)wererequiredfor90%powertodetecta
significanttreatmenteffectonbodyweightbetweenthe2studyarms.Forinsulinsensitivity,atotal
of142participants(71ineacharm)wererequiredfor90%power.Assumingthatthetreatment
effectforpostprandialmetabolismwasofthesamemagnitudeateachofthe5evaluationpoints
usedinmetabolicassessmentandthattheSDwasapproximately10.85pointsforallobservations,
with5observationsperparticipantcorrelatedatamagnitudeof0.7witheachother,andassuming
anattritionof10%,therequiredsamplesizewas81pergroup(162total)for80%powerand108per
group(216total)for90%power.
Forthesubstudyassessingtheroleofintramyocellularandhepatocellularlipidsininsulin
sensitivity,astudy26from2012providedabasisforapoweranalysis.Inthatstudy,7leanindividuals
withinsulinresistancefollowedahypocaloric(1200kcal/d)dietfor9weeks.Themean(SD)
intramyocellularlipidleveldecreasedfrom1.1%(0.2%)to0.8%(0.1%).Assumingamean(SD)
changeintheintramyocellularlipidlevelof0.3%(0.2%)intheinterventionarmandameanchange
of0withasimilarSDinthecontrolarm,tohave90%powertodetectadifferenceofthismagnitude
between,the2armswouldeachrequire11individuals(22total).Becausethiswasanexploratory
substudyandvariabilityinresponsetothedietwaslargelyunknown,20participantswererecruited
perarm(atotalof40participants).
StatisticalAnalysis
Forbaselinecharacteristics,between-groupttestswereperformedforcontinuousvariablesandχ2
orFisherexacttestforcategoricalvariables.Arepeatedmeasureanalysisofvariance(ANOVA)model
wasusedwithbetween-personandwithin-personfactorsandinteractions,includinggroup,person,
andtime.Theinteractionbetweengroupandtimewascalculatedforeachvariable.Forthermic
effectoffood,minuteswereincludedintheANOVAmodel.Datafromonlyindividualswith
measurementsatbothtimepointswereincludedintheANOVAmodel.Withineachgroup,paired
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 4/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
comparisonttestswerecalculatedtotestwhetherthechangesfrombaselineto16weekswere
statisticallysignificant.
Toeliminateskeweddatadistributionandheteroscedasticity,dataweretransformedtoa
gaussiandistributionbeforefurtherprocessingbyapowertransformationusingthestatistical
softwareStatgraphicsCenturion,versionXV(StatpointInc).Thetransformeddataunderwent
multivariableregressionusingthemethodoforthogonalprojectionstolatentstructure.27This
methodiseffectiveinaddressingseveremulticollinearitywithinthematrixofindependentvariables.
Inourmodel,changesinthermiceffectoffoodandinhepatocellularlipidlevelswerechosenasthe
dependentvariablesandthemetabolicvariables(bodyweight,fatmass,visceralfat,andinsulin
resistance)representedtheindependentvariables.Thevariabilitywasseparatedinto2independent
components.Thepredictivecomponentcontainedthevariabilityinthemetabolicvariables,which
wassharedwithchangesindependentvariables,andtheorthogonalcomponentcontainedthe
variabilitysharedwithinthemetabolicvariables.Adetaileddescriptionoftheorthogonalprojections
tolatentstructuremodelisavailableelsewhere.28ThestatisticalsoftwareSIMCA-P,version11.5
(UmetricsAB)identifiedthenumberofrelevantcomponentsusingthepredictionerrorsumof
squaresandalsoallowedthedetectionofmultivariablenonhomogeneitiesandtestingfor
multivariablenormaldistributionandhomoscedasticity(constantvariance).Thestatisticians(M.H,
R.H.)wereblindedtotheinterventionsandgroupassignment.Resultsarepresentedasmeanswith
95%CIs.Two-tailedtestswereusedtodeterminesignificanceatthe5%level.
Results
ParticipantCharacteristics
Of3115peoplescreenedbytelephone,244mettheparticipationcriteria,signedtheconsentform
andwererandomlyassignedtotheintervention(n=122)orcontrol(n=122)groupsina1:1ratio
(Figure1).Themean(SD)ageoftheinterventiongroupwas53(10)yearscomparedwith57(13)
yearsinthecontrolgroup(P=.01)(eTable1inSupplement2).Therewerenoothersignificant
differencesbetweenthegroups.Fiveinterventiongroupand16controlgroupparticipantsdropped
out,mostlyforreasonsunrelatedtothestudy,leaving223(91.0%)individualswhocompletedthe
study.eTable2inSupplement2showsthebaselinecharacteristicsofthosewhocompletedthestudy
andthosewhodroppedout.Therewerenosignificantdifferencesbetweenthesegroups.Themain
outcomesarereportedinTable1.Thetreatmenteffectswerelargelyunaffectedbytheadjustment
forageandrace/ethnicity(eTable4inSupplement2).eTable3inSupplement2showsthe
characteristicsofthesubgroupthatunderwentmagneticresonancespectroscopy.Thisgrouphada
lowerBMIcomparedwiththerestofthestudypopulation.ThemodeladjustedforbaselineBMIfor
magneticresonancespectroscopyispresentedineFigure2inSupplement2.
DietaryIntakeandPhysicalActivity
Self-reportedenergyintakedecreasedinbothgroupsbutmoresointheinterventiongroup
(treatmenteffect,−354.9kcal/d;95%CI,−519.0to−190.8kcal/d;P<.001)(Table2).Inthe
interventiongroup,meanintakesofcarbohydrateandfiberincreased,whereasmeanfat,protein,
andcholesterolintakedecreased.Thesevaluesdidnotchangesignificantlyinthecontrolgroup.
Physicalactivitydecreasedslightlyinbothgroups(−709.8metabolicequivalents[95%CI,−1346to
−73.9metabolicequivalents]inthecontrolgroupand−604.8metabolicequivalents[95%CI,−1388
to−178.6metabolicequivalents]intheinterventiongroup;between-groupP=.84).
BodyWeight,BodyComposition,andBloodLipidLevels
Meanbodyweightdecreasedby6.4kgintheinterventiongroupcomparedwith0.5kginthecontrol
group(treatmenteffect,−5.9kg;95%CI,−6.7to−5.0;interactionbetweengroupandtime,
P<.001).Thisdifferencewaslargelyattributabletoareductioninbodyfat,asnotedbysignificant
decreasesinfatmassandvisceralfatvolumeintheinterventiongroupparticipants.Totaland
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 5/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
low-densitylipoproteincholesterollevelsdecreasedby0.5mmol/Land0.4mmol/L(toconvertto
milligramsperdeciliter,divideby0.0259),respectively,intheinterventiongroup,withnosignificant
changesinthecontrolgroup(0.1mmol/Land0.07mmol/L,respectively)(P<.001forboth).
InsulinSensitivity
Fastingplasmainsulinconcentrationdecreasedby21.6pmol/L(toconverttomicro-IUpermilliliter,
divideby6.945)intheinterventiongroup,withnosignificantchangeinthecontrolgroup(23.6
pmol/L;95%CI,−5.0to54.3;between-groupP=.006).Thehomeostasismodelassessmentindex
(ameasureofinsulinresistance)decreasedsignificantly(−1.3;95%CI,−2.2to−0.3;P<.001),and
PREDIM(ameasureofinsulinsensitivity)increasedsignificantlyintheinterventiongroup(0.9;95%
CI,0.5-1.2;P<.001);neitherchangedsignificantlyinthecontrolgroup(Table2).Withinthe
interventiongroup,thechangeinPREDIMcorrelatednegativelywiththechangeinbodyweight
(r=−0.43;P<.001).
Figure1.CONSORTDiagramofParticipantFlowThroughTrial
3115Participants screened over phone
413In-person meetings
81Excluded
36Outside BMI range
3Diabetes diagnosis
7Medical exclusion
31Not willing to be in the vegan or control group
4Unable to attend weekly classes
332Signed the consent form
88Excluded
72Did not turn in their diet record or did not come to
their baseline assessment
1Family emergency
1Had medication changes and decided not
to participate
1Had already started a vegan diet
6Unable to attend weekly classes
7Withdrew
244Randomized
122Randomized to vegan diet 122Randomized to control
16Dropped out
5Dropped out 3Withdrew owing to personal reasons
1Withdrew owing to family reasons 2Not willing to be in the control or
1Withdrew owing to health reasons vegan group
1Unable to contact 2Due to health reasons
1Unable to follow diet 8Unable to contact
1Unable to attend classes 1Unable to participate in all aspects
of the study
117Completed final assessment 106Completed final assessment
117Were included in the analysis 106Were included in the analysis
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 6/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
Table1.ChangesinOutcomesDuringtheStudyintheLow-FatVeganDietaryInterventionGroupvstheControlGroup
Value,Mean(95%CI)
Controlgroup Interventiongroup
Outcome Baseline Week16 Change Baseline Week16 Change EffectSize Pvaluea
Dietaryintake
Energyintake,kcal/d 1793(1670to 1657(1548to −135.8(−250.7to 1834(1729to 1344(1260to −490.7(−607.9to −354.9(−519.0to <.001
1915) 1766) −20.8)b 1940) 1428) −373.5)c −190.8)
Fiberintake,g/d 23.9(21.9to 23.3(21.4to −0.56(−2.6to 24.1(22.1to 34.6(32.1to 10.6(7.8to 11.1(7.8to <.001
25.9) 25.3) 1.5) 26.0) 37.2) 13.3)c 14.5)
Cholesterolintake, 244.5(211.4to 230.5(196.1to −14.0(−51.7to 238.6(212.3to 5.5(3.8to −233.1(−259.4to −219.1(−264.9to <.001
mg/d 277.6) 264.9) 23.7) 265.0) 7.3) −206.8)c −173.3)
Saturatedfatty 22.9(20.5to 20.5(18.1to −2.4(−4.9to 23.6(21.4to 5.1(4.5to −18.6(−20.7to −16.2(−19.4to <.001
acids,g/d 25.3) 23.0) 0.1) 25.8) 5.6) −16.5)c −13.0)
Monounsaturatedfatty 27.9(25.2to 25.4(23.0to −2.5(−4.9to 27.2(25.3to 8.4(7.6to −18.8(−20.7to −16.3(−19.3to <.001
acids,g/d 30.7) 27.8) −0.1)b 29.1) 9.2) −16.9)c −13.3)
Polyunsaturatedfatty 19.1(17.0to 18.0(16.3to −1.1(−3.0to 18.4(16.8to 9.5(8.6to −8.9(−10.6to −7.8(−10.4to <.001
acids,g/d 21.1) 19.7) 0.9) 19.9) 10.4) −7.1)c −5.2)
Physicalactivity,METs 2863(2224to 2153(1605to −709.8(−1346to 2719(1805to 2114(1619to −604.8(−1388to 105(−898to .84
3502) 2702) −73.9)b 3633) 2609) 178.6) 1108)
Anthropometricvariables
andbodycomposition
Weight,kg 92.7(90.0to 92.2(89.4to −0.5(−1.0to 93.6(91.0to 87.2(84.9to −6.4(−7.0to −5.9(−6.7to <.001
95.3) 94.9) 0.1) 96.1) 89.6) −5.7)c −5.0)
BMI 33.6(32.9to 33.9(32.6to 0.3(−0.7to 33.3(32.6to 31.4(30.5to −1.9(−2.5to −2.2(−3.3to <.001
34.3) 35.2) 1.3) 34.0) 32.4) −1.3)c −1.1)
Fatmass,kg 40.9(39.1to 41.0(39.0to 0.01(−0.3to 40.6(38.9to 36.5(34.9to −4.1(−4.6to −4.1(−4.7to <.001
42.8) 42.9) 0.4) 42.2) 38.1) −3.6)c −3.5)
Leanmass,kg 49.5(47.9to 48.9(47.4to −0.6(−0.9to 50.5(49.0to 48.4(47.1to −2.1(−2.4to −1.5(−1.9to <.001
51.1) 50.5) −0.3)c 51.9) 49.8) −1.8)c −1.1)
VATvolume,cm3 1517(1339to 1510(1324to −7.7(−78.5to 1459(1286to 1243(1096to −216.5(−280.9to −208.8(−303.7to <.001
1695) 1695) 63.0) 1632) 1390) −152.2)c −113.7)
Hepatocellular 3.3(3.1to 3.6(3.5to 0.3(−0.5to 3.2(3.0to 2.4(2.3to −0.8(−1.5to −1.2(−2.2to .002
lipids,% 3.5) 3.8) 1.2) 3.4) 2.5) −0.1)b −0.1)
Intramyocellular 1.5(1.4to 1.7(1.5to 0.13(−0.05to 1.6(1.5to 1.5(1.4to −0.1(−0.2to −0.3(−0.4to .03
lipids,% 1.6) 1.8) 0.21) 1.7) 1.6) 0.05) −0.1)
Parametersofglucose
controlandinsulin
resistance
HbA ,DCCT,% 5.7(5.6to 5.7(5.6to 0.01(−0.04to 5.6(5.6to 5.6(5.5to −0.06(−0.12to −0.07(−0.1to .07
1c
5.8) 5.8) 0.05) 5.7) 5.7) −0.002)b 0.01)
Fastingplasmainsulin 78.9(68.3to 103.5(71.4to 23.6(−5.0to 91.2(79.9to 69.6(56.9to −21.6(−35.9to −46.2(−79.0to .006
level,pmol/L 89.4) 135.6) 54.3) 102.5) 82.3) −7.3)d −13.4)
Fastingplasmaglucose 5.0(4.7to 5.5.(5.4to 0.5(0.2to 5.2(5.1to 5.1(5.0to −0.1(−0.2to −0.6(−0.2to .001
level,mmol/L 5.4) 5.7) 0.8)c 5.3) 5.2) 0.02) −1.0)
PREDIM 4.4(4.1to 4.2(3.9to −0.2(−0.4to 4.1(3.8to 4.7(4.4to 0.7(0.5to 0.9(0.5to <.001
4.7) 4.5) 0.04) 4.3) 5.0) 0.9)c 1.2)
HOMA 2.7(2.3to 3.2(2.4to 0.5(−0.3to 3.2(2.7to 2.3(1.9to −0.8(−1.3to −1.3(−2.2to <.001
3.2) 4.0) 1.2) 3.6) 2.8) −0.3)c −0.3)
Lipidlevels,mmol/L
Totalcholesterol 5.0(4.7to 5.1(4.9to 0.1(−0.1to 5.2(5.0to 4.7(4.5to −0.5(−0.7to −0.6(−0.9to <.001
5.2) 5.3) 0.4) 5.4) 4.9) −0.4)c −0.4)
Triglycerides 1.3(1.2to 1.3(1.1to −0.01(−0.14to 1.2(1.1to 1.4(1.3to 0.2(0.08to 0.2(0.03to .02
1.4) 1.5) 0.12) 1.3) 1.5) 0.3)c 0.4)
HDLcholesterol 1.7(1.5to 1.5(1.4to −0.2(−0.4to 1.6(1.5to 1.4(1.3to −0.2(−0.3to 0.01(−0.2to .93
1.9) 1.6) −0.02)b 1.6) 1.4) −0.1)c 0.2)
LDLcholesterol 2.9(2.6to 3.0(2.9to 0.07(−0.02to 3.1(3.0to 2.7(2.5to −0.4(−1.0to −0.5(−0.8to <.001
3.1) 3.2) 0.2) 3.3) 2.9) −0.3)c −0.3)
Abbreviations:BMI,bodymassindex(calculatedasweightinkilogramsdividedby aPvaluesarefortheinteractionbetweengroupandtimeassessedbyrepeated
heightinmeterssquared);DCCT,DiabetesControlandComplicationsTrial;HbA , measuresanalysisofvariance.
1c
glycatedhemoglobin;HDL,high-densitylipoprotein;HOMA,homeostasismodel bP<.05forwithin-groupchangesfrombaselineassessedbypairedcomparisonttests.
assessment;LDL,low-densitylipoprotein;METs,metabolicequivalents;PREDIM,
cP<.001forwithin-groupchangesfrombaselineassessedbypairedcomparisonttests.
predictedinsulinsensitivityindex;VAT,visceraladiposetissue.
SIconversionfactors:ToconvertplasmainsulinleveltoμIU/mL,divideby6.945;plasma
glucoseleveltomg/dL,divideby0.0555;andlipidlevelstomg/dL,divideby0.0259.
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 7/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
PostprandialMetabolism
Postprandialenergyexpenditure(thethermiceffectoffood)increasedintheinterventiongroup
frombaselineto16weeksanddidnotchangesignificantlyinthecontrolgroup(between-group
differenceeffectsize,14.1%;95%CI,6.5%-20.4%;interactionbetweengroupandtime,P<.001)
(Figure2A).TheFvalueswereasfollows:group,F=1.7(P=.19);week,F=15.4(P<.001);time,
F=122.4(P<.001);group×week,F=11.9(P<.001);group×time,F=1.1(P=.35);week×time,
F=1.38(P=.25).Theresultsweresimilarinmodelsadjustedforageandrace/ethnicity(eFigure1in
Supplement2).Withintheinterventiongroup,thechangeinthermiceffectoffooddidnotcorrelate
significantlywithchangesinbodyweight(r=−0.15;P=.09),PREDIM(r=0.06;P=.54),energy
intake(r=0.01;P=.90),orfiberconsumption(r=0.07;P=.48).Inbothgroupscombined,changes
inthermiceffectoffoodcorrelatednegativelywithchangesinfatmass(r=−0.30;P<.05)and
positivelywithchangesinPREDIM(r=0.36;P<.05).Thatis,asfatmassdecreasedandinsulin
sensitivityimproved,postprandialmetabolismincreased(Table2).
Alinearregressionmodelforchangesinreportedenergyintakeandbodyweightshowedthat
every100kcal/dchangeinenergyintakewasassociatedwitha0.15kgchangeinbodyweight
(eFigure3inSupplement2).Themean(SD)reportedenergyreductionof355(617)kcalinthe
interventiongroupcomparedwiththecontrolgroupwouldthereforebeassociatedwithamean(SD)
weightlossof0.53(4.4)kg.Forchangesinpostprandialenergyexpenditureandbodyweight,every
changeinpostprandialenergyexpenditureof10000Uinareaunderthecurvewasassociatedwith
achangeinbodyweightof0.48kg(eFigure3inSupplement2).Themean(SD)decreasein
postprandialenergyexpenditureof8588(34020)Uofareaunderthecurvewasassociatedwithan
mean(SD)weightlossof0.41(2.8)kg.
HepatocellularandIntramyocellularLipidLevels
Inthe44participantsforwhomhepatocellularandintramyocellularlipidlevelswerequantified,
baselinehepatocellularlipidcontentwasgenerallyinthenormalrange.29,30Nonetheless,
hepatocellularlipidcontentdecreasedintheinterventiongroupby34.4%(fromamean[SD]of3.2%
[2.9%]to2.4%[2.2%];P=.03)andremainedunchangedinthecontrolgroup(fromamean[SD]of
3.3%[4.3%]to3.6%[4.7%])(group,F=3.1[P=.09];week,F=1.27[P=.27];group×week,
F=10.8[P=.002])(Figure2B).Resultsweresimilarinmodelsadjustedforageandrace/ethnicity
(eFigure1inSupplement2)andforbaselineBMI(eFigure2inSupplement2).
Withintheinterventiongroup,thedecreaseinhepatocellularlipidlevelswassignificantly
associatedwithchangeinbodyweight(r=0.42;P=.04)butnotwithchangesinreportedenergy
intake(r=0.24;P=.27)orfiberconsumption(r=0.07;P=.76).Inbothgroupscombined,changes
inhepatocellularlipidlevelscorrelatednegativelywithchangesinPREDIM(r=−0.47;P<.05).That
is,ashepatocellularlipidleveldecreased,insulinsensitivityincreased.Changesinhepatocellularlipid
Table2.RelationshipBetweenChangesinThermicEffectofFoodandtheFirstPredictiveComponentasEvaluatedbytheOPLSModel
OPLSpredictivecomponent Multipleregression
Variable Componentloadinga tStatistic Rb PvalueforR Regressioncoefficient tStatistic
MatrixX
BaselineBMI 0.191 2.46 0.209 <.05 −0.015 −0.33
Baselinefatmass 0.256 2.89 0.283 <.05 −0.014 −0.28
BaselineTEF −0.850 −11.96 −0.938 .005 −0.505 −5.69c
ChangeinPREDIM 0.324 2.41 0.359 <.05 0.105 1.37
Changeinfatmass −0.271 −2.59 −0.301 <.05 −0.122 −1.55
MatrixY
ChangeinTEF 1.000 5.27 0.540 .003 NA NA
Abbreviations:BMI,bodymassindex;NA,notapplicable;OPLS,orthogonalprojections bComponentloadingsexpressedasacorrelationcoefficientswithpredictive
tolatentstructure;PREDIM,predictedinsulinsensitivityindex;TEF,thermiceffect component.
offood.
aTheexplainedvariabilitywas29.2%(24.3%aftercross-validation).
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 8/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
levelscorrelatedpositivelywithchangesinbodyweight(r=0.91;P<.01),BMI(r=0.90;P<.01),fat
mass(r=0.91;P<.01),andvisceralfat(r=0.80;P<.01)(Table3).
Changesinintramyocellularlipidlevelswerenotstatisticallysignificantinwithin-group
comparisons,butowingtotheoppositetrends,thetreatmenteffectwassignificantlydecreasedin
theinterventiongroupby10.4%,fromamean(SD)of1.6(1.1)to1.5(1.0)(P=.03)(group,F=4.7
[P=.04];week,F=0.02[P=.88];group×week,F=5.1[P=.03])(Figure1C).Withinthe
interventiongroup(n=23),changesinbothhepatocellularandintramyocellularlipidlevels
correlatedwithchangesininsulinresistance,asmeasuredbythehomeostasismodelassessment
index(bothr=0.51;P=.01).Inbothgroupscombined,changesinintramyocellularlipidlevels
correlatedpositivelywithchangesinfatmass(r=0.51;P<.05)andhomeostasismodelassessment
indexscore(r=0.52;P<.05).Thatis,asfatmassdecreased,intramyocellularlipidlevelsandinsulin
resistancedecreased.
Discussion
Inthistrial,thedietaryinterventionreducedbodyweight,apparentlyowingtoitstendencyto
reduceenergyintakeandincreasepostprandialenergyexpenditure.Theinterventionalsoimproved
glycemiccontrolandreducedinsulinconcentrations,owinginparttoreducedlipidaccumulationin
liverandmusclecellsandthusreducedinsulinresistanceintheseorgans.
Figure2.ChangesintheThermicEffectofFood,LiverFat,andIntramyocellularLipidLevelsintheInterventionandControlGroups
4.5
4.0
3.5
3.0
2.5
2.0
1.0
gk/lack
,doof
fo
tceffe
cimrehT
A Thermic effect of food in the control group B Thermic effect of food in the intervention group
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
30 60 120 180
Time, min
gk/lack
,doof
fo
tceffe
cimrehT
1.5
30 60 120 180
Time, min
2.6
2.4
2.2
2.0
1.8
1.4
%
,taf
reviL
C Liver fat
1.8
1.6
1.5
1.6
1.3
0 16
Week
%
,sdipil
ralullecoymartnI
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
Week 0
Week 16
Week 0
Week 16
D Intramyocellular lipids
Control group
Control group
1.4
Intervention group
Intervention group
0 16
Week
Whiskersrepresent95%CIs.
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 9/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
Theinterventiondiet’seffectonweightandinsulinactionareclinicallyimportant.
Hepatocellularandintramyocellularlipidsplaycentralrolesinhepaticandmuscleinsulinresistance,
respectively,andintype2diabetes.A16-weekdietof1200kcalperdayresultedinamoderate
weightlossofapproximately8kg,whichwassufficienttonormalizeliverlipidcontentandfasting
plasmaglucoseconcentrationsaswellasreversehepaticinsulinresistanceinpatientswithobesity
andtype2diabetess.31Apotentialmechanismexplainingtheimprovementininsulinsensitivityisthe
reductioninintracellulardiacylglycerollevels,whichreduceinsulinsignalinginliverandmuscle,
leadingtotissue-specificinsulinresistance.22,32,33
Theeffectsofthedietaryinterventiononhepatocellularandintramyocellularlipidlevelsand
insulinsensitivity—thepresumedbasisfortheimprovedglycemiccontrol—hasnotpreviouslybeen
quantifiedinclinicaltrials.Energyrestrictionhasbeenshowntoreduceintramyocellularand
hepatocellularlipidlevelsandimproveglycemiccontrolinhealthyyoungindividualswithout
diabetes.26,34,35Inyoung,leanindividualswithinsulinresistance,ahypocaloricdiet(approximately
1200kcal)ledtoameanweightlossof4.1kganda30%reductionofintramyocellularlipidsduringa
9-weekintervention.26Incontrast,theinterventiondietinthepresentstudydidnotrestrictenergy
intakebutnonethelessledto34%and10%reductionsinhepatocellularandintramyocellularlipid
levels,respectively.Thereductionsinhepatocellularandintramyocellularlipidlevelscorrelatedwith
thereductioninfatmass,consistentwithpriorstudies.26,36,37
Thepresentfindingthattheincreaseinthermiceffectoffoodwasassociatedwithdecreased
fatmassandincreasedinsulinsensitivityconfirmthefindingsofpreviousresearch.38,39The
increasedinsulinsensitivitymayhavecontributedtotheincreasedpostprandialmetabolism.In
addition,increasedpostprandialmetabolismmayhavepromotedfurtherreductioninfatmassand
anincreaseininsulinsensitivity.
Despitetheadlibitumdiet,theparticipantsintheinterventiongroupreducedtheirenergy
intake,consistentwithmanyprevioustrialsusingvegandiets.Thisnotonlycontributestoweight
lossbutalsomayhavecontributedtothedecreaseinhepatocellulartriglyceridecontent.31
Postprandialmetabolismisinfluencedbymealcomposition.40-43Inthepresentstudy,however,
thetestmealwasidenticalforallstudyphases.Theseresultssuggestthattheincreasedpostprandial
thermogenesiswasattributabletoimprovedinsulinsensitivity.
Table3.RelationshipBetweenChangesinLiverFatandtheFirstPredictiveComponentasEvaluatedbyOPLSModel
OPLSpredictivecomponent Multipleregression
Variable Componentloadinga tStatistic Rb PvalueforR Regressioncoefficient tStatistic Pvaluefort
MatrixX
Controlgroup 0.339 9.88 0.795 .004 0.069 3.69 .007
Interventiongroup −0.339 −9.88 −0.795 .004 −0.069 −3.69 .007
BaselinePREDIM 0.214 8.89 0.498 .003 0.038 4.99 .005
BaselineHOMA −0.218 −2.71 −0.509 <.05 −0.060 −2.07 <.05
Baselineweight −0.228 −2.18 −0.535 <.05 −0.065 −2.19 <.05
Baselinefatmass −0.221 −2.18 −0.518 <.05 −0.058 −2.42 <.05
ChangeinPREDIM −0.199 −2.35 −0.468 <.05 −0.021 −2.54 <.05
Changeinweight 0.388 14.13 0.910 .005 0.079 5.47 .005
ChangeinBMI 0.384 13.92 0.901 .005 0.077 5.64 .003
Changeinfatmass 0.389 21.06 0.911 .002 0.078 5.87 .006
Changeinvisceralfat 0.341 8.23 0.798 .007 0.060 2.63 <.05
MatrixY
Changeinliverfat 1.000 4.66 0.495 .009 NA NA NA
Abbreviations:BMI,bodymassindex;HOMA,homeostasismodelassessment;OPLS, bComponentloadingsexpressedasacorrelationcoefficientswithpredictive
orthogonalprojectionstolatentstructure;NA,notapplicable;PREDIM,predictedinsulin component.
sensitivityindex.
aExplainedvariabilitywas24.5%(20.8%aftercross-validation).
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 10/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
StrengthsandLimitations
Thisstudyhasseveralstrengths.Therandomizedparalleldesigninwhichallparticipantswithineach
cohortbeganthestudysimultaneouslycontrolledforseasonaldietfluctuations.Thestudyduration
providedsufficienttimeforadaptationtothediet.Physiologicstimulationbyastandardmixedmeal
permittedquantificationofinsulinsensitivityandinsulinsecretionduringaphysiologicperturbation.
Measurementofvisceral,hepatocellular,andintramyocellularlipidlevels,inadditiontothedetailed
assessmentofthethermiceffectoffood,arealsostrengths.Thelowattritionsuggeststhatthe
interventionwasacceptable.
Thestudyalsohaslimitations.Self-reportsofdietaryintakehavewell-knownlimitations.44
However,itisreassuringthatthereporteddietchangeswereparalleledbychangesinweightand
plasmalipidlevels.Health-consciousparticipantsmaynotberepresentativeofthegeneral
populationbutmayberepresentativeofaclinicalpopulationseekinghelpforweightproblemsor
type2diabetes.Wefollowedtheparticipantsfor16weeksandwerenotabletoestimatetheeffects
ofthedietoveralongerperiod.Inaddition,thestudydesigndidnotallowseparationofthespecific
effectsofthelow-fatvegandietfromtheweightlossitcauses.
Conclusions
Thisrandomizedclinicaltrialfoundthatalow-fatplant-baseddietaryinterventionreducesbody
weightbyreducingenergyintakeandincreasingpostprandialmetabolism,apparentlyowingto
increasedinsulinsensitivityresultingfromreducedhepatocellularandintramyocellularfat.This
interventionmaybeaneffectivetreatmentforoverweightadults.
ARTICLEINFORMATION
AcceptedforPublication:September17,2020.
Published:November30,2020.doi:10.1001/jamanetworkopen.2020.25454
Correction:ThisarticlewascorrectedonJanuary7,2021,toedittheRoleoftheFunder/Sponsorsection;on
February1,2021,tofixerrorsintheabstractandmainResultssections;andonMay27,2021,tofixanerrorinthe
ResultssectionandeTable2inSupplement2.
OpenAccess:ThisisanopenaccessarticledistributedunderthetermsoftheCC-BYLicense.©2020KahleovaH
etal.JAMANetworkOpen.
CorrespondingAuthor:HanaKahleova,MD,PhD,PhysiciansCommitteeforResponsibleMedicine,
5100WisconsinAveNW,Ste400,Washington,DC20016(hkahleova@pcrm.org).
AuthorAffiliations:PhysiciansCommitteeforResponsibleMedicine,Washington,DC(Kahleova,Alwarith,
Rembert,Barnard);DepartmentofInternalMedicine,YaleSchoolofMedicine,NewHaven,Connecticut(Petersen,
Shulman);DepartmentofCellular&MolecularPhysiology,YaleSchoolofMedicine,NewHaven,Connecticut
(Shulman);MetabolicUnit,CNRInstituteofNeuroscience,Padua,Italy(Tura);InstituteofEndocrinology,Prague,
CzechRepublic(Hill);SchoolofMedicine,UniversityofUtah,SaltLakeCity(Holubkov);GeorgeWashington
UniversitySchoolofMedicineandHealthSciences,Washington,DC(Barnard).
AuthorContributions:DrsKahleovaandBarnardhadfullaccesstoallofthedatainthestudyandtake
responsibilityfortheintegrityofthedataandtheaccuracyofthedataanalysis.
Conceptanddesign:Kahleova,Petersen,Shulman,Barnard.
Acquisition,analysis,orinterpretationofdata:Allauthors.
Draftingofthemanuscript:Kahleova,Shulman,Alwarith,Rembert,Tura,Barnard.
Criticalrevisionofthemanuscriptforimportantintellectualcontent:Kahleova,Petersen,Shulman,Hill,Holubkov.
Statisticalanalysis:Hill,Holubkov.
Obtainedfunding:Petersen,Shulman.
Administrative,technical,ormaterialsupport:Kahleova,Petersen,Alwarith,Rembert.
Supervision:Kahleova,Petersen,Shulman,Barnard.
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 11/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
ConflictofInterestDisclosures:DrKahleovareportedbeingdirectorofclinicalresearchatthePhysicians
Committee,anonprofitorganizationthatprovidesnutritioneducationandresearch.DrRembertreported
compensationfromthePhysiciansCommitteeforResponsibleMedicineoutsidethesubmittedwork.DrHolubkov
reportedreceivingpersonalfeesfromthePhysiciansCommitteeforResponsibleMedicineduringtheconductof
thestudy.DrBarnardreportedtoservingaspresidentofthePhysiciansCommitteeforResponsibleMedicineand
BarnardMedicalCenter;receivingroyaltiesfromHachetteBookGroup,PenguinRandomHouse,Rodale,andDa
Capopublishers;andreceivinghonorariafromYale,Rush,GeorgeWashington,LomaLinda,RockfordUniversities,
MontefioreMedicalCenter,theMayoClinic,NorthwellHealth,ChristianaCare,Oticon,andtheNational
OrganizationofProfessionalAthletes.Nootherdisclosureswerereported.
Funding/Support:ThisworkwasfundedbythePhysiciansCommitteeforResponsibleMedicineandgrantsP30
DK-045735andR01DK-113984fromtheYaleDiabetesCenter(DrsShulmanandPetersen).
RoleoftheFunder/Sponsor:TheYaleDiabetesCenterhadnoroleinthedesignandconductofthestudy;
collection,management,analysis,andinterpretationofthedata;preparation,review,orapprovalofthe
manuscript;anddecisiontosubmitthemanuscriptforpublication.DrsKahleova,Alwarith,andRembert,as
employeesofPhysiciansCommitteeforResponsibleMedicine,wereinvolvedinthedesignandconductofthe
study;collection,management,analysis,andinterpretationofthedata;preparation,review,orapprovalofthe
manuscript;anddecisiontosubmitthemanuscriptforpublication.TheresearchteamofthePhysicians
CommitteeforResponsibleMedicinehadfullautonomyinallaspectsofthestudy.
DataSharingStatement:SeeSupplement3.
REFERENCES
1. QianF,LiuG,HuFB,BhupathirajuSN,SunQ.Associationbetweenplant-baseddietarypatternsandriskoftype
2diabetes:asystematicreviewandmeta-analysis.JAMAInternMed.2019.doi:10.1001/jamainternmed.2019.2195
2. TonstadS,ButlerT,YanR,FraserGE.Typeofvegetariandiet,bodyweight,andprevalenceoftype2diabetes.
DiabetesCare.2009;32(5):791-796.doi:10.2337/dc08-1886
3. BarnardND,LevinSM,YokoyamaY.Asystematicreviewandmeta-analysisofchangesinbodyweightinclinical
trialsofvegetariandiets.JAcadNutrDiet.2015;115(6):954-969.doi:10.1016/j.jand.2014.11.016
4. BarnardND,ScialliAR,Turner-McGrievyG,LanouAJ,GlassJ.Theeffectsofalow-fat,plant-baseddietary
interventiononbodyweight,metabolism,andinsulinsensitivity.AmJMed.2005;118(9):991-997.doi:10.1016/j.
amjmed.2005.03.039
5. NationalCholesterolEducationProgram.SummaryofthesecondreportoftheNationalCholesterolEducation
Program(NCEP)ExpertPanelonDetection,Evaluation,andTreatmentofHighBloodCholesterolinAdults(Adult
TreatmentPanelII).JAMA.1993;269(23):3015-3023.doi:10.1001/jama.1993.03500230097036
6. GoffLM,BellJD,SoP-W,DornhorstA,FrostGS.Veganismanditsrelationshipwithinsulinresistanceand
intramyocellularlipid.EurJClinNutr.2005;59(2):291-298.doi:10.1038/sj.ejcn.1602076
7. GojdaJ,PatkováJ,JačekM,etal.Higherinsulinsensitivityinvegansisnotassociatedwithhighermitochondrial
density.EurJClinNutr.2013;67(12):1310-1315.doi:10.1038/ejcn.2013.202
8. ItaniSI,RudermanNB,SchmiederF,BodenG.Lipid-inducedinsulinresistanceinhumanmuscleisassociated
withchangesindiacylglycerol,proteinkinaseC,andIkappaB-alpha.Diabetes.2002;51(7):2005-2011.doi:10.
2337/diabetes.51.7.2005
9. GoodpasterBH,ThaeteFL,KelleyDE.Thighadiposetissuedistributionisassociatedwithinsulinresistancein
obesityandintype2diabetesmellitus.AmJClinNutr.2000;71(4):885-892.doi:10.1093/ajcn/71.4.885
10. YatsuyaH,NihashiT,LiY,etal.Independentassociationofliverfataccumulationwithinsulinresistance.Obes
ResClinPract.2014;8(4):e350-e355.doi:10.1016/j.orcp.2013.08.002
11. SchulzKF,AltmanDG,MoherD;CONSORTGroup.CONSORT2010statement:updatedguidelinesforreporting
parallelgrouprandomisedtrials.BMCMed.2010;8(1):18.doi:10.1186/1741-7015-8-18
12. SchakelSF,SievertYA,BuzzardIM.Sourcesofdatafordevelopingandmaintaininganutrientdatabase.JAm
DietAssoc.1988;88(10):1268-1271.
13. HagströmerM,OjaP,SjöströmM.TheInternationalPhysicalActivityQuestionnaire(IPAQ):astudyof
concurrentandconstructvalidity.PublicHealthNutr.2006;9(6):755-762.doi:10.1079/PHN2005898
14. KaulS,RothneyMP,PetersDM,etal.Dual-energyX-rayabsorptiometryforquantificationofvisceralfat.
Obesity(SilverSpring).2012;20(6):1313-1318.doi:10.1038/oby.2011.393
15. NeelandIJ,GrundySM,LiX,Adams-HuetB,VegaGL.Comparisonofvisceralfatmassmeasurementbydual-
X-rayabsorptiometryandmagneticresonanceimaginginamultiethniccohort:theDallasHeartStudy.Nutr
Diabetes.2016;6(7):e221.doi:10.1038/nutd.2016.28
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 12/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
16. MellisMG,OldroydB,HindK.InvivoprecisionoftheGELunariDXAforthemeasurementofvisceraladipose
tissueinadults:theinfluenceofbodymassindex.EurJClinNutr.2014;68(12):1365-1367.doi:10.1038/ejcn.
2014.213
17. CarverTE,ChristouNV,AndersenRE.InvivoprecisionoftheGEiDXAfortheassessmentoftotalbody
compositionandfatdistributioninseverelyobesepatients.Obesity(SilverSpring).2013;21(7):1367-1369.doi:10.
1002/oby.20323
18. MatthewsDR,HoskerJP,RudenskiAS,NaylorBA,TreacherDF,TurnerRC.Homeostasismodelassessment:
insulinresistanceandbeta-cellfunctionfromfastingplasmaglucoseandinsulinconcentrationsinman.
Diabetologia.1985;28(7):412-419.doi:10.1007/BF00280883
19. TuraA,ChemelloG,SzendroediJ,etal.Predictionofclamp-derivedinsulinsensitivityfromtheoralglucose
insulinsensitivityindex.Diabetologia.2018;61(5):1135-1141.doi:10.1007/s00125-018-4568-4
20. KavianiS,SchoellerDA,RavussinE,etal.Determiningtheaccuracyandreliabilityofindirectcalorimeters
utilizingthemethanolcombustiontechnique.NutrClinPract.2018;33(2):206-216.doi:10.1002/ncp.10070
21. BlondE,MaitrepierreC,NormandS,etal.Anewindirectcalorimeterisaccurateandreliableformeasuring
basalenergyexpenditure,thermiceffectoffoodandsubstrateoxidationinobeseandhealthysubjects.e-SPEN,
theEuropeane-JournalofClinicalNutritionandMetabolism2011;6(1):e7–e15.doi:10.1016/j.eclnm.2010.12.001
22. PetersenKF,DufourS,FengJ,etal.Increasedprevalenceofinsulinresistanceandnonalcoholicfattyliver
diseaseinAsian-Indianmen.ProcNatlAcadSciUSA.2006;103(48):18273-18277.doi:10.1073/pnas.0608537103
23. LeeSS,LeeY,KimN,etal.HepaticfatquantificationusingchemicalshiftMRimagingandMRspectroscopy
inthepresenceofhepaticirondeposition:validationinphantomsandinpatientswithchronicliverdisease.JMagn
ResonImaging.2011;33(6):1390-1398.doi:10.1002/jmri.22583
24. RabølR,PetersenKF,DufourS,FlanneryC,ShulmanGI.Reversalofmuscleinsulinresistancewithexercise
reducespostprandialhepaticdenovolipogenesisininsulinresistantindividuals.ProcNatlAcadSciUSA.2011;108
(33):13705-13709.doi:10.1073/pnas.1110105108
25. GruetterR.Automatic,localizedinvivoadjustmentofallfirst-andsecond-ordershimcoils.MagnResonMed.
1993;29(6):804-811.doi:10.1002/mrm.1910290613
26. PetersenKF,DufourS,MorinoK,YooPS,ClineGW,ShulmanGI.Reversalofmuscleinsulinresistanceby
weightreductioninyoung,lean,insulin-resistantoffspringofparentswithtype2diabetes.ProcNatlAcadSciUS
A.2012;109(21):8236-8240.doi:10.1073/pnas.1205675109
27. TryggJ,HolmesE,LundstedtT.Chemometricsinmetabonomics.JProteomeRes.2007;6(2):469-479.doi:10.
1021/pr060594q
28. SosvorovaL,HillM,MohaplM,VitkuJ,HamplR.Steroidhormonesinpredictionofnormalpressure
hydrocephalus.JSteroidBiochemMolBiol.2015;152:124-132.doi:10.1016/j.jsbmb.2015.05.004
29. RomeoS,KozlitinaJ,XingC,etal.GeneticvariationinPNPLA3conferssusceptibilitytononalcoholicfattyliver
disease.NatGenet.2008;40(12):1461-1465.doi:10.1038/ng.257
30. SzczepaniakLS,NurenbergP,LeonardD,etal.Magneticresonancespectroscopytomeasurehepatic
triglyceridecontent:prevalenceofhepaticsteatosisinthegeneralpopulation.AmJPhysiolEndocrinolMetab.
2005;288(2):E462-E468.doi:10.1152/ajpendo.00064.2004
31. PetersenKF,DufourS,BefroyD,LehrkeM,HendlerRE,ShulmanGI.Reversalofnonalcoholichepaticsteatosis,
hepaticinsulinresistance,andhyperglycemiabymoderateweightreductioninpatientswithtype2diabetes.
Diabetes.2005;54(3):603-608.doi:10.2337/diabetes.54.3.603
32. PetersenMC,ShulmanGI.Mechanismsofinsulinactionandinsulinresistance.PhysiolRev.2018;98(4):
2133-2223.doi:10.1152/physrev.00063.2017
33. SamuelVT,ShulmanGI.Mechanismsforinsulinresistance:commonthreadsandmissinglinks.Cell.2012;148
(5):852-871.doi:10.1016/j.cell.2012.02.017
34. Lara-CastroC,NewcomerBR,RowellJ,etal.Effectsofshort-termverylow-caloriedietonintramyocellular
lipidandinsulinsensitivityinnondiabeticandtype2diabeticsubjects.Metabolism.2008;57(1):1-8.doi:10.1016/j.
metabol.2007.05.008
35. JazetIM,SchaartG,GastaldelliA,etal.Lossof50%ofexcessweightusingaverylowenergydietimproves
insulin-stimulatedglucosedisposalandskeletalmuscleinsulinsignallinginobeseinsulin-treatedtype2diabetic
patients.Diabetologia.2008;51(2):309-319.doi:10.1007/s00125-007-0862-2
36. SinhaR,DufourS,PetersenKF,etal.Assessmentofskeletalmuscletriglyceridecontentby(1)Hnuclear
magneticresonancespectroscopyinleanandobeseadolescents:relationshipstoinsulinsensitivity,totalbodyfat,
andcentraladiposity.Diabetes.2002;51(4):1022-1027.doi:10.2337/diabetes.51.4.1022
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 13/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
JAMANetworkOpen | Nutrition,Obesity,andExercise EffectofaLow-FatVeganDietonMetabolicMeasuresinOverweightAdults
37. MoroC,GalganiJE,LuuL,etal.Influenceofgender,obesity,andmusclelipaseactivityonintramyocellular
lipidsinsedentaryindividuals.JClinEndocrinolMetab.2009;94(9):3440-3447.doi:10.1210/jc.2009-0053
38. CamastraS,BonoraE,DelPratoS,RettK,WeckM,FerranniniE;EGIR(EuropeanGroupfortheStudyofInsulin
Resistance).Effectofobesityandinsulinresistanceonrestingandglucose-inducedthermogenesisinman.IntJ
ObesRelatMetabDisord.1999;23(12):1307-1313.doi:10.1038/sj.ijo.0801072
39. RavussinE,AchesonKJ,VernetO,DanforthE,JéquierE.Evidencethatinsulinresistanceisresponsibleforthe
decreasedthermiceffectofglucoseinhumanobesity.JClinInvest.1985;76(3):1268-1273.doi:10.1172/JCI112083
40. BowdenVL,McMurrayRG.Effectsoftrainingstatusonthemetabolicresponsestohighcarbohydrateand
highfatmeals.IntJSportNutrExercMetab.2000;10(1):16-27.doi:10.1123/ijsnem.10.1.16
41. NagaiN,SakaneN,MoritaniT.Metabolicresponsestohigh-fatorlow-fatmealsandassociationwith
sympatheticnervoussystemactivityinhealthyyoungmen.JNutrSciVitaminol(Tokyo).2005;51(5):355-360.doi:
10.3177/jnsv.51.355
42. ThyfaultJP,RichmondSR,CarperMJ,PotteigerJA,HulverMW.Postprandialmetabolisminresistance-trained
versussedentarymales.MedSciSportsExerc.2004;36(4):709-716.doi:10.1249/01.MSS.0000121946.98885.F5
43. BarrSB,WrightJC.Postprandialenergyexpenditureinwhole-foodandprocessed-foodmeals:implications
fordailyenergyexpenditure.FoodNutrRes.2010;54:54.doi:10.3402/fnr.v54i0.5144
44. YuanC,SpiegelmanD,RimmEB,etal.Relativevalidityofnutrientintakesassessedbyquestionnaire,24-hour
recalls,anddietrecordscomparedwithurinaryrecoveryandplasmaconcentrationbiomarkers:findingsfor
women.AmJEpidemiol.2017.doi:10.1093/aje/kww104
SUPPLEMENT1.
TrialProtocol
SUPPLEMENT2.
eTable1.Baselinecharacteristicsofthestudypopulation
eTable2.Baselinecharacteristicsofthestudypopulation,comparingstudycompletersanddrop-outs
eTable3.Baselinecharacteristicsofthestudypopulation,comparingthesubsampleundergoingmagnetic
resonancespectroscopy(MRS)withtherestofthestudypopulation
eTable4.Treatmenteffectsforthemainoutcomes,adjustedforageandrace
eFigure1.Changesinthethermiceffectoffood,liverfat,andintramyocellularlipidsafteradjustmentforraceand
age
eFigure2.ChangesinliverfatandintramyocellularlipidsafteradjustmentforbaselineBMI
eFigure3.Linearregressionmodelforchangesinenergyandbodyweightandpostprandialenergyexpenditure
andbodyweight
SUPPLEMENT3.
DataSharingStatement
JAMANetworkOpen.2020;3(11):e2025454.doi:10.1001/jamanetworkopen.2020.25454 (Reprinted) November30,2020 14/14
Downloaded from jamanetwork.com by Chinese University of Hong Kong, Frankie Cheung on 08/24/2024
